Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
215.39
120.73
107.95
145.82
204.63
294.25
351.29
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
215.39
120.73
107.95
145.82
204.63
294.25
351.29
Raw Material Cost
128.47
102.37
93.27
106.29
131.42
154.62
226.37
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
27.49
25.97
18.99
29.17
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.65
7.24
7.45
7.51
7.12
6.33
8.97
Selling and Distribution Expenses
53.58
39.99
50.11
62.37
101.53
150.72
109.22
Other Expenses
-0.44
-0.68
-3.34
-3.21
-2.55
-3.07
-0.14
Total Expenditure (Excl Depreciation)
183.25
142.84
144.96
169.99
233.60
310.11
343.16
Operating Profit (PBDIT) excl Other Income
32.1
-22.1
-37
-24.2
-29
-15.9
8.100000000000001
Other Income
5.06
1.91
-0.59
-1.48
5.52
65.49
1.38
Operating Profit (PBDIT)
57.36
-6.84
-26.40
-16.25
-15.90
57.52
20.76
Interest
5.65
7.24
7.45
7.51
7.12
6.33
8.97
Exceptional Items
-0.58
-6.00
-17.72
4.62
-16.85
15.83
1.81
Gross Profit (PBDT)
86.93
18.36
14.68
39.53
73.21
139.63
124.92
Depreciation
22.05
16.23
20.77
14.60
10.74
13.55
14.20
Profit Before Tax
29.07
-36.31
-72.34
-33.73
-50.61
53.47
-0.60
Tax
7.21
2.99
0.76
-0.95
0.94
1.41
6.07
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
15.25
-38.28
-67.52
-29.80
-40.52
50.68
-9.88
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
15.25
-38.28
-67.52
-29.80
-40.52
50.68
-9.88
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
6.62
-1.02
-5.61
-2.98
-11.03
1.38
3.21
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
21.87
-39.30
-73.12
-32.78
-51.55
52.06
-6.66
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
52.38
37.14
-14.59
45.18
72.84
101.81
55.56
Earnings per share (EPS)
0.13
-0.31
-0.55
-0.24
-0.33
0.42
-0.08
Diluted Earnings per share
0.13
-0.31
-0.55
-0.24
-0.33
0.42
-0.08
Operating Profit Margin (Excl OI)
14.05%
-20.69%
-43.15%
-20.14%
-15.72%
-7.31%
1.48%
Gross Profit Margin
23.73%
-16.64%
-47.77%
-13.12%
-19.49%
22.78%
3.87%
PAT Margin
7.08%
-31.7%
-62.54%
-20.44%
-19.8%
17.22%
-2.81%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 78.46% vs 11.76% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 155.73% vs 46.24% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 701.15% vs 66.28% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -20.83% vs -4.00% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
215.39
0
215.39
Other Operating Income
0.00
0.00
0.00
Total Operating income
215.39
0
215.39
Raw Material Cost
128.47
0
128.47
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5.65
0
5.65
Selling and Distribution Expenses
53.58
0
53.58
Other Expenses
-0.44
0.00
-0.44
Total Expenditure (Excl Depreciation)
183.25
0
183.25
Operating Profit (PBDIT) excl Other Income
32.14
0.00
32.14
Other Income
5.06
0
5.06
Operating Profit (PBDIT)
57.36
0
57.36
Interest
5.65
0
5.65
Exceptional Items
-0.58
0
-0.58
Gross Profit (PBDT)
86.93
0
86.93
Depreciation
22.05
0
22.05
Profit Before Tax
29.07
0
29.07
Tax
7.21
0
7.21
Provisions and contingencies
0
0
0.00
Profit After Tax
15.25
0
15.25
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
15.25
0
15.25
Share in Profit of Associates
0
0
0.00
Minority Interest
6.62
0
6.62
Other related items
0.00
0.00
0.00
Consolidated Net Profit
21.87
0
21.87
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
52.38
0
52.38
Earnings per share (EPS)
0.13
0
0.13
Diluted Earnings per share
0.13
0
0.13
Operating Profit Margin (Excl OI)
14.05%
0%
0.00
14.05%
Gross Profit Margin
23.73%
0%
0.00
23.73%
PAT Margin
7.08%
0%
0.00
7.08%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 21.54 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 78.46% vs 11.76% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 2.19 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 155.73% vs 46.24% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.23 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 701.15% vs 66.28% in Dec 2023
Annual - Interest
Interest 0.57 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -20.83% vs -4.00% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.05%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
